Literature DB >> 16987514

The protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation and increases sarcoplasmic/endoplasmic reticulum calcium ATPase 2 levels.

Taj D King1, Johanna C Gandy, Gautam N Bijur.   

Abstract

The ubiquitously expressed protein glycogen synthase kinase-3 (GSK3) is constitutively active, however its activity is markedly diminished following phosphorylation of Ser21 of GSK3alpha and Ser9 of GSK3beta. Although several kinases are known to phosphorylate Ser21/9 of GSK3, for example Akt, relatively much less is known about the mechanisms that cause the dephosphorylation of GSK3 at Ser21/9. In the present study KCl-induced plasma membrane depolarization of SH-SY5Y cells, which increases intracellular calcium concentrations caused a transient decrease in the phosphorylation of Akt at Thr308 and Ser473, and GSK3 at Ser21/9. Overexpression of the selective protein phosphatase-1 inhibitor protein, inhibitor-2, increased basal GSK3 phosphorylation at Ser21/9 and significantly blocked the KCl-induced dephosphorylation of GSK3beta, but not GSK3alpha. The phosphorylation of Akt was not affected by the overexpression of inhibitor-2. GSK3 activity is known to affect sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) levels. Overexpression of inhibitor-2 or treatment of cells with the GSK3 inhibitors lithium and SB216763 increased the levels of SERCA2. These results indicate that the protein phosphatase-1/inhibitor-2 complex differentially regulates GSK3 dephosphorylation induced by KCl and that GSK3 activity regulates SERCA2 levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987514      PMCID: PMC1885546          DOI: 10.1016/j.yexcr.2006.08.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  45 in total

Review 1.  The glamour and gloom of glycogen synthase kinase-3.

Authors:  Richard S Jope; Gail V W Johnson
Journal:  Trends Biochem Sci       Date:  2004-02       Impact factor: 13.807

Review 2.  Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.

Authors:  Armen S Manoukian; James R Woodgett
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

Review 3.  Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

Authors:  Stefan E Hardt; Junichi Sadoshima
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

4.  Localization and quantification of endoplasmic reticulum Ca(2+)-ATPase isoform transcripts.

Authors:  K D Wu; W S Lee; J Wey; D Bungard; J Lytton
Journal:  Am J Physiol       Date:  1995-09

Review 5.  The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.

Authors:  Oksana Kaidanovich; Hagit Eldar-Finkelman
Journal:  Expert Opin Ther Targets       Date:  2002-10       Impact factor: 6.902

6.  Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

Authors:  Fang Zhang; Christopher J Phiel; Laura Spece; Nadia Gurvich; Peter S Klein
Journal:  J Biol Chem       Date:  2003-06-07       Impact factor: 5.157

Review 7.  Functional diversity of protein phosphatase-1, a cellular economizer and reset button.

Authors:  Hugo Ceulemans; Mathieu Bollen
Journal:  Physiol Rev       Date:  2004-01       Impact factor: 37.312

8.  Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Authors:  Effat S Emamian; Diana Hall; Morris J Birnbaum; Maria Karayiorgou; Joseph A Gogos
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

9.  Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart.

Authors:  Ashour Michael; Syed Haq; Xin Chen; Eileen Hsich; Lei Cui; Brian Walters; Zhili Shao; Kausik Bhattacharya; Heiko Kilter; Gordon Huggins; Michele Andreucci; Muthu Periasamy; Robert N Solomon; Ronglih Liao; Richard Patten; Jeffery D Molkentin; Thomas Force
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

Review 10.  Inhibition of protein kinase B/Akt. implications for cancer therapy.

Authors:  Michelle M Hill; Brian A Hemmings
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

View more
  14 in total

1.  PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha.

Authors:  Iris Eke; Ulrike Koch; Stephanie Hehlgans; Veit Sandfort; Fabio Stanchi; Daniel Zips; Michael Baumann; Anna Shevchenko; Christian Pilarsky; Michael Haase; Gustavo B Baretton; Véronique Calleja; Banafshé Larijani; Reinhard Fässler; Nils Cordes
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  Transcriptional mechanisms regulating Ca(2+) homeostasis.

Authors:  Michael F Ritchie; Yandong Zhou; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

3.  Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate.

Authors:  Thomas K Creson; Peixiong Yuan; Husseini K Manji; Guang Chen
Journal:  J Mol Neurosci       Date:  2008-08-03       Impact factor: 3.444

4.  Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells.

Authors:  Tatyana S Nekova; Susanne Kneitz; Hermann Einsele; Gernot Stuhler
Journal:  Cell Cycle       Date:  2014-05-20       Impact factor: 4.534

5.  Behavioral stress-induced activation of FoxO3a in the cerebral cortex of mice.

Authors:  Wenjun Zhou; Ligong Chen; Sufen Yang; Fuzeng Li; Xiaohua Li
Journal:  Biol Psychiatry       Date:  2011-10-05       Impact factor: 13.382

6.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

7.  Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.

Authors:  Yongfang Jiang; Hui Bao; Yan Ge; Wei Tang; Du Cheng; Kaizhong Luo; Guozhong Gong; Rujun Gong
Journal:  Gut       Date:  2014-05-08       Impact factor: 23.059

8.  Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.

Authors:  Gauri A Patwardhan; Salman B Hosain; David X Liu; Sachin K Khiste; Yunfeng Zhao; Jacek Bielawski; S Michal Jazwinski; Yong-Yu Liu
Journal:  Biochim Biophys Acta       Date:  2014-09-06

9.  Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer.

Authors:  Kazuhide Watanabe; Jacob Biesinger; Michael L Salmans; Brian S Roberts; William T Arthur; Michele Cleary; Bogi Andersen; Xiaohui Xie; Xing Dai
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  Interaction between Neuronal Depolarization and MK-801 in SH-SY5Y Cells and the Rat Cortex.

Authors:  Yeni Kim; Miran Seo; Yun-Il Lee; So-Young Kim; Eun-Ah Cho; Se-Hyun Kim; Yong-Min Ahn; Ung-Gu Kang; Yong-Sik Kim; Yong-Sung Juhnn
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.